EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS175-07196 
Organism
Homo sapiens 
Tissue/cell
SK-N-MC 
Coordinate
chr12:133020430-133023430 
TF binding sites/motifs
Number: 28             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
ATF3MA0605.2chr12:133022695-133022707GATGACGTCACC+6.74
ATF3MA0605.2chr12:133022796-133022808GATGACGTCACC+6.74
ATF3MA0605.2chr12:133022847-133022859GATGACGTCACC+6.74
ATF3MA0605.2chr12:133022897-133022909GATGACGTCACC+6.74
ATF3MA0605.2chr12:133022695-133022707GATGACGTCACC-6.92
ATF3MA0605.2chr12:133022796-133022808GATGACGTCACC-6.92
ATF3MA0605.2chr12:133022847-133022859GATGACGTCACC-6.92
ATF3MA0605.2chr12:133022897-133022909GATGACGTCACC-6.92
CREB1MA0018.3chr12:133022644-133022656TATGACGTCACC+6.02
CREB1MA0018.3chr12:133022745-133022757TATGACGTCACC+6.02
CREB1MA0018.3chr12:133022644-133022656TATGACGTCACC-6.02
CREB1MA0018.3chr12:133022745-133022757TATGACGTCACC-6.02
CREB1MA0018.3chr12:133022695-133022707GATGACGTCACC+6.74
CREB1MA0018.3chr12:133022796-133022808GATGACGTCACC+6.74
CREB1MA0018.3chr12:133022847-133022859GATGACGTCACC+6.74
CREB1MA0018.3chr12:133022897-133022909GATGACGTCACC+6.74
CREB1MA0018.3chr12:133022695-133022707GATGACGTCACC-6.74
CREB1MA0018.3chr12:133022796-133022808GATGACGTCACC-6.74
CREB1MA0018.3chr12:133022847-133022859GATGACGTCACC-6.74
CREB1MA0018.3chr12:133022897-133022909GATGACGTCACC-6.74
JDP2(var.2)MA0656.1chr12:133022644-133022656TATGACGTCACC+6.14
JDP2(var.2)MA0656.1chr12:133022745-133022757TATGACGTCACC+6.14
JDP2(var.2)MA0656.1chr12:133022695-133022707GATGACGTCACC+6.92
JDP2(var.2)MA0656.1chr12:133022796-133022808GATGACGTCACC+6.92
JDP2(var.2)MA0656.1chr12:133022847-133022859GATGACGTCACC+6.92
JDP2(var.2)MA0656.1chr12:133022897-133022909GATGACGTCACC+6.92
KLF4MA0039.3chr12:133023350-133023361CCACACCCTCC+6.32
PRDM1MA0508.2chr12:133021450-133021460TCACTTTCAC+6.02
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_10775chr12:133020028-133023469CD19_Primary
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 3             
ChromosomeStartEnd
chr12133021598133021727
chr12133021781133022391
chr12133021534133022956
Number: 1             
IDChromosomeStartEnd
GH12I132443chr12133020139133023744
Enhancer Sequence
CTGTGAACCC CATCCATTGT AGCCTTGATT TCTAGAAGTT TGGTTTGCAT ATTTTTAAAT 60
GGTCTATGTT TCTACTTAGC TCTTTCAACA CAGGGAATGC AGTCAGGATG ACTGTCAGTG 120
TCTGTCTGGC GATTCTAACA CTTGTGTTAG TTCTGACCAG GATTTCGCAG TGGATTTTTC 180
CTCCCCTTAC GGGTGGGTTT TCCTGCTTCC CCGAATGTAA TCTTTGAATC GATGGCAGAC 240
ATTGTTAACA TCGCCTTTGT TGGGTGTGGA TGTTTGTGTT TATGTGGAAA CATTCCTGCA 300
CCTTTTTCTG GCGTGCGGTT CAGTTACATG GAAAAGGTTT GGCCTCTCAG GTCTTATTTT 360
AAAGTGGCCG TCAGGGCCGA ATGTTCTGCC CATTTTGTCC ACACTAATTA TCCCTCTTTG 420
GGGAGCAAGA CCCTTGTGAG ATGCCACCGC CACCCTCGGG AGGCCTCCAG GCTGGGGGAC 480
GGGCACTGTG GGCTGCTGGT GTAGGGCCGG ACGCTCTCTG ACAGTGTTGC CCCTGGCCTC 540
CGGCGGCTTC CTCCCAAGCT GGGTTGGGGC TCTTCTGAAC GCTCCCCTCC ATGCCCTGTC 600
CTGGGAACTT TAACCCTCTG GGCCTCCCGG AGCCCTCTGT CTCCCCTGTC CCAGGGGGTC 660
TGCTGGGCTC CACCGGGCCC CGCCCTGAAT GCAGCCTGGA GCAACGCTGG AGGCCGGGGC 720
TAGGAAACTG TGAGCCCCGC CTTGTCTGTG TCTTTCTCAG GGATTCTCGT CCTTTCCAAC 780
CTGGTGCCCG ATGTCCGGAA GCACCTCTTC TGTGTTTTCA AATGGGAGAG CGAATCCAGT 840
CCTTTTCACT CCATTTTGGC CAGAAACAGA AGTCCTCCGT GATTTATATT TTTACTAGAA 900
TCTTTTAAAG GGGCACAAAT GGGGGTGTTT TGCAGGCATA CAGAAGCCCC CGTCACTCCT 960
CCCGCCTTGT CTCTGAACCG CTGTGGGGTG GGGAGGGGTC TCTTCTCTCT CCAACCCACA 1020
TCACTTTCAC CCCCCGCCGG CCAAGGCTGC GTTTCCCTCG CCCCCACCCC AGTCCCCCGC 1080
GTTGGTAGTG GGATCGGTTT GGTATTCTGA GGCTTCTCTC ATTTCTCCTT TATCACCATC 1140
TGCCCCACAG CAGGCAGGCC CGGAGCCTCT GCAGAAGGGG GAACCGGGTG CAGGCCCAAC 1200
GCCGGTCTCT CAGTGTGGCA GCCTTGCGCG CGAGCAGAAG CAGAAGGCCT AGTTCCTACT 1260
CTGCAGCCTT GGCTGCCGGG CACGGAGAAC GTTTTAGCAG AAACACCTCT GCAAAACCAC 1320
TTCCTGGCCC GGGCCCAGCC AAACACCATC TTCTCCTCCA CCCCAGGGCT CCGCCCCCAT 1380
CTCCAGGCTC AGCCCAGCAC CCCCACCCCC GAAACCCCCA GCCCCACTGC ATCTGCCCTG 1440
GCCATCTGCC TCCGCCCTGC CTCGCTAACA CAGTTATTAA TGAGCAATTT TCCTGTAATT 1500
ACAACGCAGT TATGCCAGTT ACCCCGACCT GCTGACAGAG AGCATTCACT TCCATGTGGC 1560
ACTAGCCCCC AGGCCTGAGA GGACGCAAAC ACTTGCCCCT CATTCGCTGC CCCCACCCCC 1620
ACTCTGCCAG CCAGCACCAC CCTCCACCCA CTCTAGGCCC TTAAGAAAGG AGGGAAGGGC 1680
CGCGGGGAGG AGCTCTCAGA TCCCGAGGCC CCACTCCCCC TGCAAGGAAG GCTGTGAGCT 1740
CGGCCCCAGC CCACCTGCCA GCTCCCCAAA CACCTCCCAC CTCCCTCCGC CGCCTCCTGA 1800
AGGGACTACA CTCCCCTGGC TCCTCCAAAA TCCGCTAATG AACAGCAGGC GCAGAGGCTC 1860
CGCCACCGGC GTGCTCCTGG CCTCAGCCCT CCCTGTTCTG AAACCGCCTT TGCTAAGACG 1920
GTAGTAGTGA GGAATCACGA CAGTGGCAGA GGCCAACCTG ACCCGCTCCA CCTGCCTCCA 1980
CCCCAACCCG CCCGGCTGCT TCCTGAGCGT GGGCCAAACT AACTTTGACA GGAACTTAGT 2040
TTACAGTTTA AGTTGGGAAC AAAAAGGATA ACAGCCCCTC CCCAAAACAG ATTCCCTCCT 2100
CGCTTGGGGG GACCAGTCCC GTTGTAAAAC CGACAAATAA CAGCAGGATT AGGAATTCCG 2160
GCTCAGGATT CACGCAGCCA GACGCCACAG GACTCCTCCC CAGCCGCTCC TGTATATGAC 2220
GTCACCGCCG TAAGACCACA GGACACCGCC CCAGCCGCGC CTGTAGATGA CGTCACCATC 2280
GTAAGACCAC AGGACCCTTC CCAGCCGCTC CTGTATATGA CGTCACCGCC GTAAGACCAC 2340
AAGTCACCGC CCCAGCCGCT CCTGTAGATG ACGTCACCAC AGTAAGACCA CAGGATACCG 2400
CCCCAGCCGC GCCTGTAGAT GACGTCACCA TCGTAGGCCC ACAGGACCCT TCCCAGCCGC 2460
TCCTGTGGAT GACGTCACCG CCGTAGGACC TAAGATTGAT GCTGGAGAGG TTCTTCAGAC 2520
CCTGCGTTCT GACGGCTCCG CTGGCACCAC CCAGACGGGT AAACTAGCTC TTCCGGTCTG 2580
TGGCCCTCAC AGGAACCGAC TCGGTGCAGG AGGACAGCTT CAGCCCCTGT GATTTCATCC 2640
CCGACCAACC AGCCAGCACT CCCCACTCCC TAGCCCCCTG CCTGCCAAAC TATCTTTTAA 2700
AAAACTCCAG TTTCCAAATT TTCAGGGAGG CTGATTTGAG TAATAATAAA ACTCCAGTCT 2760
CCTGCTAGCT GGCTCTGGAT GCACTAGACT CTATTGCAAT TCTCCTGTCC TGATAAATCG 2820
GCTGTCAGGC AAGAAGAACC CGTTGGGTGG TTACAGTTTC AAGGCTATAT TCAGAGAACT 2880
ATCCACTAAT AAAATCTCTG TTTATGCAGT AGGTCCCACC CCACACCCTC CCTGCTCAAA 2940
CTGCTGCAAT CCCGGCACAG CTTTGTTGAC AATGTACCCA TCAGCCAACA AAATGTAACA 3000